Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2017 | |
| Sales | 0 | 3,553 | 1,430 | 42,000 | 0 |
| Gross Profit | N/A | 3,553 | 1,430 | 42,000 | N/A |
| Operating Expenses | 33,844 | 35,956 | 33,327 | 26,181 | 0 |
| Operating Income | -33,844 | -32,403 | -31,897 | 15,819 | N/A |
| Interest Expense | 2,919 | 2,251 | 1,764 | 1,333 | 0 |
| Other Income | 952 | 11,989 | 49,459 | 76 | 0 |
| Pre-tax Income | -35,811 | -22,665 | 15,798 | 14,562 | 0 |
| Income Tax | N/A | N/A | N/A | 351 | N/A |
| Net Income Continuous | -35,811 | -22,665 | 15,798 | 14,211 | N/A |
| Net Income | $-35,811 | $-22,665 | $15,798 | $14,211 | $N/A |
| EPS Basic Total Ops | -16.37 | -13.76 | 26.25 | 3.00 | N/A |
| EPS Basic Continuous Ops | -16.37 | -13.76 | 26.15 | 251.79 | N/A |
| EPS Diluted Total Ops | -16.37 | -13.76 | 11.00 | 2.75 | N/A |
| EPS Diluted Continuous Ops | -16.37 | -13.76 | 10.97 | 133.81 | N/A |
| EPS Diluted Before Non-Recurring Items | -16.37 | -13.75 | 11.00 | N/A | N/A |
| EBITDA(a) | $-34,206 | $-32,387 | $-31,873 | $15,979 | $N/A |